Alliance Pharma seeks acquisitions as sales up 27%

20 January 2022 - Deborah Wilkes

Premium

Alliance Pharma is seeking further consumer healthcare deals after the acquisition of Amberen helped lift its sales by 27% at constant currencies to GBP170 million (USD227 million) in 2021.

Click tags below for more information on topics:

Alliance Pharma

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: